We developed a digital health strategy and identified multiple growth opportunities based on changing patient needs and the rise of new technologies.
F. Hoffmann LA Roche is a multinational life-sciences company that operates worldwide under two divisions: pharmaceuticals and diagnostics. Compared to the pharmaceutical sector, the business value of diagnostics has been historically lower. Change is in the air: as new technologies are shifting the focus of healthcare from cure to care, diagnostics is the first field to benefit from this transformation.
In this scenario, Roche invited Board of Innovation to Basel to co-create a digital strategy and design and execute an innovation vision and strategy to discover new digital health offerings for Roche, with the aim to do what patients need next!
Board of Innovation had impact by:
